{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:42:51Z","timestamp":1761986571808},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Miller-Fisher Syndrome (MFS) is a variant of Guillain\u2013Barr\u00e9 syndrome (GBS), an acute immune-mediated neuropathy, which manifests as a rapidly evolving areflex motor paralysis. This syndrome presents as a classic triad: ophthalmoplegia, areflexia, and ataxia. MFS is usually benign and self-limited.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case report<\/jats:title>\n                <jats:p>A Caucasian patient was admitted to our hospital with the flu, loss of bilateral strength in the lower limbs and upper limbs and sudden-onset ataxia 7 days after receiving a first dose of the Oxford\/AstraZeneca COVID-19 vaccine. On neurological examination, the patient had Glasgow Coma Scale score of 15, with absence of meningeal signs; negative Babinski sign; grade 2 strength in the lower limbs and grade 4 strength  in the upper limbs; axial and appendicular cerebellar ataxia; and peripheral facial diparesis predominantly on the right, without conjugate gaze deviation. Cerebrospinal fluid (CSF) was collected on admission, and analysis revealed albuminocytological dissociation with CSF protein of 148.9 mg\/dL; leukocytes, 1; chlorine, 122; glucose, 65 mg\/mL; red cells, 2; and non-reactive venereal disease research laboratory test result. The COVID-19 IgG\/IgM rapid immunological test was negative. Electroneuromyography revealed a recent moderate-grade and primarily sensory and motor demyelinating polyneuropathy with associated proximal motor block.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion and conclusion<\/jats:title>\n                <jats:p>Miller-Fisher Syndrome may be related to events other than infections prior to neuropathy, as in the case reported here. The patient presented strong correlations with findings for MFS reported in the literature, such as the clinical condition, the results of electroneuromyography, and results of the CSF analysis typical for MFS. When treatment was provided as proposed in the literature, the disease evolved with improvement. Ultimately, the diagnosis of incomplete MFS was made, including acute ataxic neuropathy (without ophthalmoplegia).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-022-03592-4","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T14:04:03Z","timestamp":1668607443000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Miller\u2013Fisher syndrome after first dose of Oxford\/AstraZeneca coronavirus disease 2019 vaccine: a case report"],"prefix":"10.1186","volume":"16","author":[{"given":"Fernanda Junqueira Cesar","family":"Pirola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno Ant\u00f4nio M\u00fczel","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela Feres","family":"Sapienza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas Yuri","family":"Cetrangolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caio Henrique Wthen Gambacorta","family":"Geranutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Henrique Pires","family":"de Aguiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"issue":"10045","key":"3592_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","volume":"388","author":"HJ Willison","year":"2016","unstructured":"Willison HJ, Jacobs BC, van Doorn PA. Guillain\u2013Barr\u00e9 syndrome. Lancet. 2016;388(10045):717\u201327.","journal-title":"Lancet."},{"issue":"5","key":"3592_CR2","first-page":"512","volume":"32","author":"JW Teener","year":"2012","unstructured":"Teener JW. Miller Fisher\u2019s syndrome. Semin Neurol. 2012;32(5):512\u20136.","journal-title":"Semin Neurol"},{"key":"3592_CR3","unstructured":"Larry J, Hauser SL, Amato AA. Guillain\u2013Barr\u00e9 syndrome and other immune-mediated neuropathies. In: Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editors. Harrison\u2019s internal medicine. 20th Edition. New York: McGraw-Hill Education; 2019. p. 3225\u201331."},{"issue":"5","key":"3592_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1055\/s-0039-1693005","volume":"39","author":"E Malek","year":"2019","unstructured":"Malek E, Salameh J. Guillain-Barre syndrome. Semin Neurol. 2019;39(5):589\u201395.","journal-title":"Semin Neurol"},{"issue":"6","key":"3592_CR5","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/ICU.0000000000000611","volume":"30","author":"B Al Othman","year":"2019","unstructured":"Al Othman B, Raabe J, Kini A, Lee AG. Update. Curr Opin Ophthalmol. 2019;30(6):462\u20136.","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"3592_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-243629","volume":"14","author":"T Hasan","year":"2021","unstructured":"Hasan T, Khan M, Khan F, Hamza G. Case of Guillain\u2013Barr\u00e9 syndrome following COVID-19 vaccine. BMJ Case Rep. 2021;14(6): e243629.","journal-title":"BMJ Case Rep"},{"issue":"4","key":"3592_CR7","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00415-020-10124-x","volume":"268","author":"S Abu-Rumeileh","year":"2021","unstructured":"Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Guillain\u2013Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol. 2021;268(4):1133\u201370.","journal-title":"J Neurol"},{"key":"3592_CR8","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3389\/fneur.2020.00518","volume":"11","author":"MU Ahmed","year":"2020","unstructured":"Ahmed MU, Hanif M, Ali MJ, Haider MA, Kherani D, Memon GM, et al. Neurological manifestations of COVID-19 (SARS-CoV-2): a review. Front Neurol. 2020;11:518.","journal-title":"Front Neurol"},{"issue":"4","key":"3592_CR9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/mus.27024","volume":"62","author":"JB Caress","year":"2020","unstructured":"Caress JB, Castoro RJ, Simmons Z, Scelsa SN, Lewis RA, Ahlawat A, et al. COVID-19-associated Guillain\u2013Barr\u00e9 syndrome: the early pandemic experience. Muscle Nerve. 2020;62(4):485\u201391.","journal-title":"Muscle Nerve"},{"issue":"11","key":"3592_CR10","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1007\/s10072-020-04693-y","volume":"41","author":"K Rahimi","year":"2020","unstructured":"Rahimi K. Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports. Neurol Sci. 2020;41(11):3149\u201356.","journal-title":"Neurol Sci"},{"key":"3592_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jocn.2020.04.062","volume":"76","author":"Z Sedaghat","year":"2020","unstructured":"Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci. 2020;76:233\u20135.","journal-title":"J Clin Neurosci"},{"issue":"6","key":"3592_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-236182","volume":"13","author":"S Webb","year":"2020","unstructured":"Webb S, Wallace VC, Martin-Lopez D, Yogarajah M. Guillain\u2013Barr\u00e9 syndrome following COVID-19: a newly emerging post-infectious complication. BMJ Case Rep. 2020;13(6): e236182.","journal-title":"BMJ Case Rep"},{"key":"3592_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-217085","volume":"2016","author":"SK Gupta","year":"2016","unstructured":"Gupta SK, Jha KK, Chalati MD, Alashi LT. Miller Fisher syndrome. BMJ Case Rep. 2016;2016:bcr2016217085.","journal-title":"BMJ Case Rep"},{"issue":"4","key":"3592_CR14","doi-asserted-by":"publisher","first-page":"E15","DOI":"10.1002\/mus.25487","volume":"55","author":"AC Rizzo","year":"2017","unstructured":"Rizzo AC, Ulivi M, Brunelli N, Pepe A, Assenza G, Florio L, et al. A case of Miller Fisher Syndrome associated with preceding herpes zoster ophthalmicus. Muscle Nerve. 2017;55(4):E15\u20136.","journal-title":"Muscle Nerve"},{"issue":"3","key":"3592_CR15","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","volume":"29","author":"JJ Sejvar","year":"2011","unstructured":"Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, et al. Guillain\u2013Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29(3):599\u2013612.","journal-title":"Vaccine"},{"key":"3592_CR16","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1007\/s00415-021-10479-9","volume":"268","author":"J Rath","year":"2021","unstructured":"Rath J, Zulehner G, Schober B, Grisold A, Krenn M, Cetin H, et al. Cerebrospinal fluid analysis in Guillain\u2013Barr\u00e9 syndrome: value of albumin quotients. J Neurol. 2021;268:3294.","journal-title":"J Neurol"},{"issue":"27","key":"3592_CR17","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020;383(27):2603\u201315.","journal-title":"N Engl J Med"},{"issue":"2","key":"3592_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41591-021-01230-y","volume":"27","author":"JH Kim","year":"2021","unstructured":"Kim JH, Marks F, Clemens JD. Looking beyond COVID-19 vaccine phase 3 trials. Nat Med. 2021;27(2):205\u201311.","journal-title":"Nat Med"},{"key":"3592_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ana.26144","volume":"90","author":"CM Allen","year":"2021","unstructured":"Allen CM, Ramsamy S, Tarr AW, Tighe PJ, Irving WL, Tanasescu R, et al. Guillain\u2013Barr\u00e9 syndrome variant occurring after SARS-CoV-2 vaccination. Ann Neurol. 2021;90:315.","journal-title":"Ann Neurol"},{"issue":"4","key":"3592_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-242956","volume":"14","author":"SU Patel","year":"2021","unstructured":"Patel SU, Khurram R, Lakhani A, Quirk B. Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1. BMJ Case Rep. 2021;14(4): e242956.","journal-title":"BMJ Case Rep"},{"key":"3592_CR21","volume":"13","author":"S Waheed","year":"2021","unstructured":"Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cures. 2021;13: e13426.","journal-title":"Cures"},{"issue":"20","key":"3592_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029333","volume":"101","author":"AR Siddiqi","year":"2022","unstructured":"Siddiqi AR, Khan T, Tahir MJ, Asghar MS, Islam MS, Yousaf Z. Miller Fisher syndrome after COVID-19 vaccination: case report and review of literature. Medicine (Baltimore). 2022;101(20): e29333.","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"3592_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-246701","volume":"14","author":"YL Dang","year":"2021","unstructured":"Dang YL, Bryson A. Miller\u2013Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination. BMJ Case Rep. 2021;14(11): e246701.","journal-title":"BMJ Case Rep"},{"key":"3592_CR24","unstructured":"UK Government. Information for healthcare professionals on COVID-19 vaccine AstraZeneca. https:\/\/www.gov.uk\/government\/publications\/regulatory-approval-of-covid-19-vaccineastrazeneca\/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca-regulation-174."}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03592-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-022-03592-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03592-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T14:06:42Z","timestamp":1668607602000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-022-03592-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3592"],"URL":"https:\/\/doi.org\/10.1186\/s13256-022-03592-4","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"assertion":[{"value":"30 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"437"}}